1. Home
  2. KYMR vs OPEN Comparison

KYMR vs OPEN Comparison

Compare KYMR & OPEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KYMR
  • OPEN
  • Stock Information
  • Founded
  • KYMR 2015
  • OPEN 2014
  • Country
  • KYMR United States
  • OPEN United States
  • Employees
  • KYMR N/A
  • OPEN N/A
  • Industry
  • KYMR Medicinal Chemicals and Botanical Products
  • OPEN Real Estate
  • Sector
  • KYMR Health Care
  • OPEN Finance
  • Exchange
  • KYMR Nasdaq
  • OPEN Nasdaq
  • Market Cap
  • KYMR 4.3B
  • OPEN 4.9B
  • IPO Year
  • KYMR 2020
  • OPEN N/A
  • Fundamental
  • Price
  • KYMR $59.70
  • OPEN $7.14
  • Analyst Decision
  • KYMR Strong Buy
  • OPEN Sell
  • Analyst Count
  • KYMR 17
  • OPEN 4
  • Target Price
  • KYMR $63.76
  • OPEN $1.45
  • AVG Volume (30 Days)
  • KYMR 771.9K
  • OPEN 189.0M
  • Earning Date
  • KYMR 10-30-2025
  • OPEN 11-06-2025
  • Dividend Yield
  • KYMR N/A
  • OPEN N/A
  • EPS Growth
  • KYMR N/A
  • OPEN N/A
  • EPS
  • KYMR N/A
  • OPEN N/A
  • Revenue
  • KYMR $44,711,000.00
  • OPEN $5,181,000,000.00
  • Revenue This Year
  • KYMR $62.11
  • OPEN N/A
  • Revenue Next Year
  • KYMR N/A
  • OPEN N/A
  • P/E Ratio
  • KYMR N/A
  • OPEN N/A
  • Revenue Growth
  • KYMR N/A
  • OPEN 14.07
  • 52 Week Low
  • KYMR $19.45
  • OPEN $0.51
  • 52 Week High
  • KYMR $63.96
  • OPEN $10.87
  • Technical
  • Relative Strength Index (RSI)
  • KYMR 62.28
  • OPEN 47.76
  • Support Level
  • KYMR $58.00
  • OPEN $6.97
  • Resistance Level
  • KYMR $63.96
  • OPEN $7.89
  • Average True Range (ATR)
  • KYMR 2.65
  • OPEN 0.78
  • MACD
  • KYMR 0.00
  • OPEN -0.34
  • Stochastic Oscillator
  • KYMR 56.84
  • OPEN 11.90

About KYMR Kymera Therapeutics Inc.

Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.

About OPEN Opendoor Technologies Inc

Opendoor Technologies Inc is an end-to-end real estate platform enabling customers to sell and buy a home online. Its product offerings include Sell to Opendoor, its core product where sellers sell their homes directly to the company, and it resells those homes to buyers; List with Opendoor, for customers to list their homes with a partner agent; and Opendoor Marketplace, a capital light marketplace offering that connects home sellers with both institutional and retail buyers. In addition to these products, the company also offers its customers integrated title insurance and escrow services through its subsidiaries. A vast majority of the company's revenue is generated by its core product offering, where it acquires homes directly from sellers and resells those homes to buyers.

Share on Social Networks: